Trial intelligence / Profile preview

Pilot Study of Pegylated Interferon and Entecavir in Chronic Hepatitis B

NCT01589952Phase 2Unknown

Sponsor
Bangabandhu Sheikh Mujib Medical University
Start
Mar 2012
Primary completion
Feb 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of peginterferon alfa-2a, entecavir in Chronic Hepatitis B (CHB), sponsored by Bangabandhu Sheikh Mujib Medical University. Status: unknown.

02

Drugs

peginterferon alfa-2aentecavir
03

Conditions

Chronic Hepatitis B (CHB)

Beyond the preview

Go deeper on NCT01589952.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01589952.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call